| 000 | 01293 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513201343.0 | ||
| 264 | 0 | _c20000203 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0022-3573 | ||
| 024 | 7 |
_a10.1211/0022357991776958 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVanderbist, F | |
| 245 | 0 | 0 |
_aOptimization of a dry powder inhaler formulation of nacystelyn, a new mucoactive agent. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacy and pharmacology _cNov 1999 |
||
| 300 |
_a1229-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aCapsules |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 |
_aExpectorants _xadministration & dosage |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aLactose |
| 650 | 0 | 4 |
_aLysine _xadministration & dosage |
| 650 | 0 | 4 | _aMicroscopy, Electron, Scanning |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPowders |
| 650 | 0 | 4 | _aSolubility |
| 700 | 1 | _aWery, B | |
| 700 | 1 | _aMoyano-Pavon, I | |
| 700 | 1 | _aMoës, A J | |
| 773 | 0 |
_tThe Journal of pharmacy and pharmacology _gvol. 51 _gno. 11 _gp. 1229-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1211/0022357991776958 _zAvailable from publisher's website |
| 999 |
_c10587531 _d10587531 |
||